This average rate decrease will lower total premiums by an estimated $130 million.
Blue Cross and Blue Shield of North Carolina (Blue Cross NC) is lowering premiums by 4% for individuals and families who enroll in Affordable Care Act (ACA) plans in 2024. This will lower total premiums by an estimated $130 million, plan executives said in a press release. Blue Cross NC is a not-for-profit plan that provides health insurance to 4.2 million members.
Rates are largely determined by the cost of members’ collective medical and pharmacy claims, but they also based on location, age and plan. For individual ACA customers, customers’ premium amounts depend on federal premium subsidy levels, which will be determined by the Centers for Medicare and Medicaid Services in October. About 85% of Blue Cross NC’s current customers with individual ACA plans qualify for subsidies for their 2024 plans.
Blue Cross NC said that it has worked to negotiate lower costs with drug manufacturers. While prescription drug costs in the United States grew 9.4% in 2022, Blue Cross NC was able to hold down the overall pharmacy trend for its individual ACA market to 0.7% in 2022 and to 2.9%, so far in 2023, according to the plan.
Open enrollment for people under the age of 65 for ACA plans begins on Nov. 1, 2023, and ends on Jan. 15, 2024. Beginning in 2024, Blue Cross NC will offer its preferred provider organization (PPO) plan, Blue Advantage, in every county. The plan also is working with other local systems to provide Blue Local and Blue Home plans (with monthly rates that are $100 to $200 lower than a similar PPO), as well as Blue Value plans (with monthly rates that are $70 to $90 lower than a similar PPO plan) in some counties in the state.
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
A Motor Neuron Mystery Points to New Potential SMA Treatment Targets
December 20th 2024Some muscles are resistant to the loss of motor neurons seen in patients with spinal muscular atrophy, and new research has discovered that even in muscles that appeared resistant to SMA, subtle changes had occurred at the cellular level.
Read More